Uterine and tubal factor subfertility

When you have completed this course, you will be able to:

• aetiology of uterine and tubal factor subfertility
• different investigation modalities available
• management options available
• importance of prevention.

Shilpi Pandey FRCOG (2020, 2024)

Consultant in Reproductive Medicine and Medical Director at CARE Fertility Nottingham. She completed her specialty training in Obstetrics and Gynaecology from Wales deanery and then worked as a clinical research fellow in the Assisted Reproduction Unit in the University of Aberdeen, Scotland. She has extensive clinical experience in all aspects of Reproductive Medicine including fertility preservation for cancer patients, individualisation of treatment protocols and management of patients with complex medical problems, preimplantation genetic screening and pre implantation genetic diagnosis.

This course is intended to help clinicians gain core knowledge for O&G training and the MRCOG examinations. It can also be used by O&G consultants to refresh their knowledge of the area or for teaching.

National Institute for Health and Care Excellence. Fertility Problems: Assessment and Treatment. CG156. London: NICE; 2017.

Melo P, Georgio EX, Johnson N, van Voorst S, Strandell A, Mol BWJ: Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2020; CD002125.

Fields E, Chard J, James D, Treasure T; Guideline Development Group. Fertility (update): summary of NICE guidance. BMJ 2013;346:f650.

Nwokolo NC, Dragovic B, Patel S, William Tong CY, Baker G, Radcliffe K; BASHH. National guideline for management of Genital tract infection with Chlamydia trachomatis. Int J STI AIDS 2016;27:251-267.

NICE Clinical Knowledge summaries: Pelvic inflammatory disease last updates 2019.